|
MCID: MYS023
|
Myasthenia Gravis, Neonatal Transient malady |
|
Sources: 22MalaCards See all sources Export this MalaCard |
MalaCards: Myasthenia Gravis, Neonatal Transient, also known as myasthenia gravis, is related to thymoma and neonatal myasthenia gravis. An important gene associated with Myasthenia Gravis, Neonatal Transient is CHRNG (cholinergic receptor, nicotinic, gamma (muscle)). The drugs cyclophosphamide and cyclosporine have been mentioned in the context of this disorder.
|
|
Sources: 43UMLS, 33OMIM See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for myasthenia gravis, neonatal transient Drug clinical trials:Search ClinicalTrials for myasthenia gravis, neonatal transient Search NIH Clinical Center for myasthenia gravis, neonatal transient Search CenterWatch for myasthenia gravis, neonatal transient Inferred drug relations via UMLS/NDF-RT:43 28 cyclophosphamide, cyclosporine, pyridostigmine, pyridostigmine bromide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|